Neuronal lipid metabolism: multiple pathways driving functional outcomes in health and disease

TJ Tracey, FJ Steyn, EJ Wolvetang… - Frontiers in molecular …, 2018 - frontiersin.org
Lipids are a fundamental class of organic molecules implicated in a wide range of biological
processes related to their structural diversity, and based on this can be broadly classified …

Molecular and cellular mechanisms affected in ALS

L Le Gall, E Anakor, O Connolly… - Journal of personalized …, 2020 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a terminal late-onset condition characterized by the
loss of upper and lower motor neurons. Mutations in more than 30 genes are associated to …

Biomarkers in motor neuron disease: a state of the art review

NS Verber, SR Shepheard, M Sassani… - Frontiers in …, 2019 - frontiersin.org
Motor neuron disease can be viewed as an umbrella term describing a heterogeneous
group of conditions, all of which are relentlessly progressive and ultimately fatal. The …

Metabolomics of human brain aging and age-related neurodegenerative diseases

M Jové, M Portero-Otín, A Naudí, I Ferrer… - … of Neuropathology & …, 2014 - academic.oup.com
Neurons in the mature human central nervous system (CNS) perform a wide range of motor,
sensory, regulatory, behavioral, and cognitive functions. Such diverse functional output …

Neurodegenerative disorders of alzheimer, parkinsonism, amyotrophic lateral sclerosis and multiple sclerosis: an early diagnostic approach for precision treatment

N Pathak, SK Vimal, I Tandon, L Agrawal… - Metabolic Brain …, 2021 - Springer
Neurodegenerative diseases (NDs) are characterised by progressive dysfunction of
synapses, neurons, glial cells and their networks. Neurodegenerative diseases can be …

Untargeted metabolomics yields insight into ALS disease mechanisms

SA Goutman, J Boss, K Guo, FM Alakwaa… - Journal of Neurology …, 2020 - jnnp.bmj.com
Objective To identify dysregulated metabolic pathways in amyotrophic lateral sclerosis (ALS)
versus control participants through untargeted metabolomics. Methods Untargeted …

[PDF][PDF] Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma

X Wang, A Zhang, H Sun - Hepatology, 2013 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the commonest primary hepatic malignancy and the third
most common cause of cancer‐related death worldwide. Incidence remains highest in the …

Metabolic biomarkers and neurodegeneration: a pathway enrichment analysis of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis

M Kori, B Aydın, S Unal, KY Arga… - Omics: a journal of …, 2016 - liebertpub.com
Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD),
and amyotrophic lateral sclerosis (ALS) lack robust diagnostics and prognostic biomarkers …

The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism

S Pavlides, A Tsirigos, G Migneco… - Cell cycle, 2010 - Taylor & Francis
A loss of stromal Cav-1 in the tumor fibroblast compartment is associated with early tumor
recurrence, lymph-node metastasis, and tamoxifen-resistance, resulting in poor clincical …

The glutamate hypothesis in ALS: pathophysiology and drug development

H Blasco, S Mavel, P Corcia… - Current medicinal …, 2014 - ingentaconnect.com
Amyotrophic lateral sclerosis (ALS) is an age-related neurodegenerative disorder that is
believed to have complex genetic and environmental influences in the pathogenesis, but …